Clinical Trials Logo

Acne Vulgaris clinical trials

View clinical trials related to Acne Vulgaris.

Filter by:

NCT ID: NCT02249104 Completed - Acne Vulgaris Clinical Trials

A Treatment Regimen for Student Athletes With Mild to Moderate Acne Vulgaris

Start date: August 2014
Phase: Phase 4
Study type: Interventional

The goal of this study is to evaluate a complete topical acne regimen consisting of a prescription acne medication (Epiduo® Gel) and an acne-specific cleanser (Cetaphil® DermaControlâ„¢ Foam Wash) and moisturizer with sunscreen (Cetaphil® DermaControlâ„¢ Moisturizer SPF 30) for safety, efficacy and patient satisfaction in student athletes with acne vulgaris.

NCT ID: NCT02242760 Completed - Acne Vulgaris Clinical Trials

P2 Multi-center Study of SB204 Gel in the Treatment of Acne Vulgaris

Start date: November 2014
Phase: Phase 2
Study type: Interventional

This is a randomized, multi-center, double-blinded study in subjects with moderate to severe acne vulgaris. Subjects eligible to enroll will be treated once or twice daily with 2 concentrations of a topical drug in development or a vehicle. Subjects will be treated for up to 12 weeks.

NCT ID: NCT02219074 Completed - Acne Vulgaris Clinical Trials

Multiple Arm Study of Sebacia Microparticles in the Treatment of Acne Vulgaris

Start date: June 2011
Phase: N/A
Study type: Interventional

Prospective, multicenter study with multiple arms to examine the safety and effectiveness of the Sebacia Acne Treatment System for the treatment of acne vulgaris.

NCT ID: NCT02218034 Completed - Acne Vulgaris Clinical Trials

Safety, Tolerability and Pharmacokinetics of AGN-190168 in Subjects With Acne Vulgaris

Start date: August 2014
Phase: Phase 1
Study type: Interventional

This is a safety, tolerability and pharmacokinetics study of AGN-190168 in subjects with acne vulgaris.

NCT ID: NCT02217228 Completed - Clinical trials for Inflammatory Acne Vulgaris

Pivotal Study of Sebacia Microparticles in the Treatment of Acne Vulgaris

Start date: September 2014
Phase: N/A
Study type: Interventional

Prospective, randomized multicenter study to examine the safety and effectiveness of Sebacia microparticles with or without laser in the treatment of moderate to moderately-severe inflammatory acne vulgaris

NCT ID: NCT02189629 Completed - Acne Vulgaris Clinical Trials

CD5789 (Trifarotene) Long Term Safety Study on Acne Vulgaris

Start date: February 23, 2015
Phase: Phase 3
Study type: Interventional

Multi-center, open-label, non-comparative safety and efficacy study with 52 Weeks of treatment on the face and trunk for acne vulgaris.

NCT ID: NCT02164084 Completed - Acne Vulgaris Clinical Trials

A 2 Period Cross-over Pharmacokinetic Study of SB204 in Acne Vulgaris

Start date: June 2014
Phase: Phase 1
Study type: Interventional

This study will identify how much (if any) drug is absorbed from the skin of subjects with acne vulgaris after topical application of SB204.

NCT ID: NCT02160678 Completed - Acne Vulgaris Clinical Trials

Generic Tazarotene Cream, 0.1% in the Treatment of Acne Vulgaris

Start date: May 2014
Phase: Phase 3
Study type: Interventional

To compare the safety and efficacy profiles of Tazarotene Cream, 0.1 % to the reference listed drug Tazorac® (tazarotene) Cream, 0.1 % in order to demonstrate bioequivalence, and to demonstrate superiority of the 2 active creams over that of the cream vehicle (placebo) in the treatment of acne vulgaris.

NCT ID: NCT02103816 Completed - Acne Scars Clinical Trials

The Smartlipo Triplex 1440nm Wavelength Laser and the Sidelaze 800 Hand Piece for the Treatment of Facial Acne Scars

Start date: October 2013
Phase: N/A
Study type: Interventional

The purpose of this study to evaluate the SmartLipo Triplex laser system along with the SideLaze800 hand piece in the treatment of Acne Scars.

NCT ID: NCT02103127 Completed - Acne Scars Clinical Trials

Evaluation of the Picosure 755nm Alexandrite Laser With Lens Array for the Treatment of Acne Scars

Start date: July 2013
Phase: N/A
Study type: Interventional

The purpose of this study is to assess treatment of facial acne scars using the 755nm Alexandrite Laser with lens arrays.